PF-4var/CXCL4L1 Predicts Outcome in Stable Coronary Artery Disease Patients with Preserved Left Ventricular Function

• Johan De Sutter,

  Affiliations Department of Cardiology, AZ Maria Middelares Ghent, Ghent, Belgium, Heart Centre, Ghent University Hospital, Ghent, Belgium

  ⨯
• Nico R. Van de Veire,

  Affiliations Department of Cardiology, AZ Maria Middelares Ghent, Ghent, Belgium, Faculty of Medicine and Pharmacy, Free University Brussels, Brussels, Belgium

  ⨯
• Sofie Struyf,

  Affiliation Laboratory of Molecular Immunology, Rega Institute, University of Leuven, Leuven, Belgium

  ⨯
• Jan Philippé,

  Affiliation Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium

  ⨯
• Marc De Buyzere,

  Affiliation Heart Centre, Ghent University Hospital, Ghent, Belgium

  ⨯
• Jo Van Damme

  * E-mail: jo.vandamme@rega.kuleuven.be

  Affiliation Laboratory of Molecular Immunology, Rega Institute, University of Leuven, Leuven, Belgium

  ⨯